乳癌及び前立腺癌における診断的及び治療的使用のための癌性疾患修飾抗体

Title:

乳癌及び前立腺癌における診断的及び治療的使用のための癌性疾患修飾抗体

Document Type and Number:

Japanese Patent JP2009529009

Kind Code:

A

Abstract:

The present invention relates to a method for producing patient cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells.

More Like This:

WO/2024/044549	VHH ANTIBODY CONJUGATES
WO/2019/101871	A NEW MARKER FOR PREDICTING THE SENSITIVITY TO PI3K INHIBITORS
WO/1999/002567	COMPOSITIONS AND METHODS FOR PRODUCING HOMOCONJUGATES OF ANTIBODIES WHICH INDUCE GROWTH ARREST OR APOPTOSIS OF TUMOR CELLS

Inventors:

Young, David, S., F.
Hahn, Susan, Yi.
Findlay, Helen, Pee.

Application Number:

JP2008557560A

Publication Date:

August 13, 2009

Filing Date:

March 05, 2007

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Arias Research, Inc.

International Classes:

C07K16/32; A61K38/00; A61K39/395; A61K47/48; A61P35/00; A61P37/04; C07K16/46; C12P21/08

Attorney, Agent or Firm:

Kazunori Saito
Tetsuya Ito

Previous Patent: Ｎ−ホルミルヒドロキシルアミン化合物

Next Patent: 癌性疾患修飾抗体